SMTL ID : 7ok4.1

Crystal Structure of KRasG13C in Complex with Nucleotide-based covalent Inhibitor bdaGDP

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x VJB: bdaGDP(Covalent)

VJB.1: 20 residues within 4Å: Chain A: A.12, C.14, V.15, G.16, K.17, S.18, A.19, F.29, V.30, D.31, E.32, Y.33, A.60, N.117, K.118, D.120, L.121, S.146, A.147, K.148 20 PLIP interactions: 20 interactions with chain A Hydrogen bonds: A:C.14, A:V.15, A:G.16, A:K.17, A:S.18, A:A.19, A:D.31, A:E.32, A:N.117, A:K.118, A:K.118, A:A.147, A:K.148 Water bridges: A:K.17, A:S.18, A:S.18 Salt bridges: A:K.17, A:D.120 pi-Stacking: A:F.29, A:F.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Goebel, L. et al., Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. Elife (2023)

Release Date

2022-08-03

Peptides

Isoform 2B of GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Isoform 2B of GTPase KRas

Related Entries With Identical Sequence